MoneyWorks4Me

Laurus Labs informs about investor conference

12 Jun 2025 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Laurus Labs has informed that the Company will be participating in the Investor Conference in one-on-one meetings and group meetings, as details enclosed. No Unpublished Price Sensitive Information will be shared during the meetings.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..